Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
8.23M
-
Shares change
-
-253K
-
Total reported value, excl. options
-
$20.3M
-
Value change
-
+$3.12M
-
Put/Call ratio
-
4.47
-
Number of buys
-
24
-
Number of sells
-
-38
-
Price
-
$2.47
Significant Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q2 2025
84 filings reported holding MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share as of Q2 2025.
Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.23M shares
of 17.3M outstanding shares and own 47.71% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (1.32M shares), Prosight Management, LP (900K shares), VANGUARD GROUP INC (773K shares), ACORN CAPITAL ADVISORS, LLC (654K shares), ORBIMED ADVISORS LLC (589K shares), Newtyn Management, LLC (570K shares), LMR Partners LLP (516K shares), Diametric Capital, LP (350K shares), MILLENNIUM MANAGEMENT LLC (316K shares), and BlackRock, Inc. (286K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.